top of page
>
>
Portfolio planning and management
Client Problems
- A mid-size biotechnology company wanted to organize its proprietary therapeutic technology portfolio for 3 disease areas
- They wanted a framework to for portfolio management to drive growth and realize full potential of the platform technology through product and portfolio assessments
- Specifically, they wanted to identify opportunities, gaps and risks in the portfolio and enable selection and prioritize new programs for internal portfolio
What We Did
- Initiated a portfolio prioritization methodology and process
- Established portfolio criteria and metrics based on technical, commercial, operations and strategic fit considerations
- Rank and prioritize programs in the portfolio alongside external benchmarks
- Determined the effect of pricing and reimbursement scenarios on the portfolio assets and performed a sensitivity analysis for each scenario
Our Results And Insight
- Portfolio planning methodology
- Technical and commercial summary of assets
- Score based prioritization of portfolio assets
- Overview of opportunities, gaps and risk analysis
- Prioritization based on timing, technical and commercial factors
- Impact of pricing and reimbursement models on portfolio asset sales






See other case studies
Commercial Strategy case studies >
Portfolio Management case studies >
Gene Therapy & Orphan Disease case studies >
Service Areas Details
Commercial Strategy (Indication Prioritization)
Therapeutic Areas Details
Gene Therapy & Orphan Disease
Featured Consultants
bottom of page